2nd Annual Risk Management and Pharmacovigilance America Summit 2017

2nd Annual Risk Management and Pharmacovigilance America Summit comes as a continuation of the successful last year´s meeting of the best PV experts on the market. This upcoming October, we will discuss a wide range of topics and areas within drug safety and risk management. As we all know, this field is very important for the whole population and it absolutely requires the constant education and sharing expertise of the best PV professionals. If you want to stay updated with the current Pharmacovigilance issues, do not miss this meeting hold on 24 - 26 October in Boston. Companies such as Astellas, GSK, Merck, Janssen, CSL Behring, Sanofi Pasteur, Otsuka and many more will share case studies and their opinions on topics such as Risk Minimization, Social listening, Outsourcing of Pharmacovigilance, Data Management and Data Mining, RMPs update, function of the Safety Management Teams, New technologies in PV and many others. 


Co - Located With

6th Annual Patient Recruitment & Retention America Summit


Key Speakers

Milbor D'Silva

Vice President, Head of Safety Science & Site Head for VP Pharmacovigilance

Astellas Pharma Global Development

Susan Welsh

Chief Safety Officer 

CSL Behring

Harry Seifert
Executive Director, Clinical Safety Sciences

GlaxoSmithKline Vaccines


Annie Tougas

Associate Director, Pharmacovigilance & Medical Information

Otsuka Canada Pharmaceutical Inc.

Ann Straus



Key topics

  • Lessons learned from the risk minimization strategies
  • Function of the Safety Management Teams
  • Safety Review of products in development and post-marketing
  • What are the potential uses for social media to improve drug safety?
  • Vendor management and outsourcing of pharmacovigilance services
  • New definitions in the Maternal Immunization (MI) Pharmacovigilance
  • Risk Management Plans rule amendments
  • Evolving themes for Safety Signal Detection in Clinical Development and post-marketing
  • New technologies in Pharmacovigilance
  • Benefit-Risk Management


Who Should attend

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments from pharmaceutical involved in:

  • Drug Safety
  • Pharmacovigilance
  • Risk Management
  • Clinical Safety
  • Data management and data mining
  • Safety & Risk Management
  • Signal Detection
  • Benefit-Risk Assessment
  • Safety Evaluation
  • Regulatory Affairs, Pharmacovigilance


  • PV Governance
  • Safety Surveillance
  • Pharmacovigilance Operations
  • PV Inspection and Audit Readiness
  • Patient Support Programs
  • Market Research Programs
  • Medical Safety
  • Medical Information 
  • Pharmacoepidemiology


A.      The Risk Management and Pharmacovigilance America Summit will be a great opportunity to meet     the worldwide experts in the drug safety field. After our successful PV and RM meetings in Europe, we are moving to another continent and you have the chance to be part of it. In October, Boston will be the place, where the top experts from companies such as Merck, Pfizer, Amgen, Novartis, Genentech, Gilead Sciences, Takeda and others, will speak about interesting case studies from different areas within the drug safety. You will get the best advices on how to implement new legislation into the real world settings, how to deal with increasing volumes of ICSRs, how to improve the pharmacovigilance and risk management procedures in your company, Benefit-Risk Evaluations and frameworks, signal detection, the future of pharmacovigilance, comparison of the US, EU and Latin America pharmacovigilance processes, etc. You will also find many networking and discussing opportunities there, where you will be able to exchange practical insights with other participants and pharmacovigilance/risk management experts. Save the date from 18th to 20th October and do not miss any news from the pharmacovigilance world in 2016. 

Join us and register today

Stay on top of the latest trends

Key speakers

Key topics

Who Should Attend